Nova Ltd vs QXO Inc. Common Stock — how do they compare? Nova Ltd trades at $330.07 (market cap $10.89B), while QXO Inc. Common Stock trades at $10.33 (market cap $11.43B). The key difference: Nova Ltd and QXO Inc. Common Stock are close in size by market cap, and Nova Ltd is trading nearer its 52-week high, QXO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nova Ltd for 6 Days and QXO Inc. Common Stock for 0 Days on average.
| NVMI | QXO | |
|---|---|---|
Market Cap | $10.89B | $11.43B |
Volume | 416,153 | 21,645,941 |
Sector | Technology | Industrials |
52-Week High | $605.65 | $27.07 |
52-Week Low | $275.78 | $10.33 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $10.67B | $16.75B |
Signals from Pluang's Aura AI — not financial advice
NVMI trades at $342.37, up 0.58% on the day, with a bearish technical signal driven by moving averages but supported by strong fundamentals including a 28.84% net income margin and three consecutive quarterly earnings beats. The stock is positioned near its pivot point of $344, with immediate support at $336. Revenue growth is projected to increase from $881 million in 2025 to $937 million in 2026, though net cash flow turned negative in 2026.
The outlook remains positive given the 85.7% analyst buy rating and a consensus price target of $556.50, implying significant upside. Key risks include high valuation multiples like a P/E of 42.64 and negative cash flow trends, but the company's tool-of-record status in AI chip packaging provides a durable growth catalyst.
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →